How Much Dividend Does Pfizer Pay? | Yield And Payout

This guide walks through how much dividend Pfizer pays right now, how that number has changed over time, and what drives the yield. By the end, you should have a solid view of what the current payout means for different share counts and risk levels, so you can decide where Pfizer fits inside your own income strategy for most investors.

Pfizer Dividend Snapshot And Main Numbers

Before digging into fine detail, it helps to see the main Pfizer dividend statistics in one place. These figures are based on public data as of late 2025 and will move over time as earnings, board decisions, and the share price shift.

Dividend Metric	Recent Value	Brief Description
Quarterly dividend per share	$0.43	Cash paid every three months on each common share.
Annual dividend per share	About $1.72	Four quarterly payments combined over a full year.
Dividend yield	Around 6.6%	Annual dividend divided by the current share price.
Payment frequency	Quarterly	Four standard payouts each calendar year.
Recent ex-dividend date	Early November 2025	Date by which you must own shares to receive that quarter’s cash.
Years of consecutive dividends	More than 80 years	Long record of making regular cash payments.
Years of recent annual raises	About 14–16 years	Sustained stretch with at least one raise each year.
Recent payout ratio range	Near 60% on adjusted earnings	Portion of profit returned to shareholders as dividends.

How Much Dividend Does Pfizer Pay? By Quarter And Year

So when you ask, “how much dividend does pfizer pay?” the answer starts with the latest board declaration. In October 2025 the board approved a quarterly cash dividend of $0.43 per share, continuing the same level that has applied through the year. That payment, scheduled for early December, marks the 348th straight quarterly dividend from the company.

Multiply that quarterly amount by four and you get an annual dividend of about $1.72 per share. If you owned 100 shares during the full year and stayed in before each ex-dividend date, that adds up to roughly $172 in gross cash. Taxes and any brokerage charges will change what appears in your account, yet the base math is simple: share count times the per share amount. That math keeps expectations grounded and clear.

Pfizer posts each declaration, ex-dividend date, and pay date on its official dividend and split history page, which lets you verify the current rate and see past changes.

Quarterly Dividend Pattern

Dividend checks from Pfizer usually arrive four times a year, with record dates in early February, May, August, and November and payments a few weeks later. The exact calendar shifts slightly from year to year, yet long term income holders tend to count on a roughly even payout through the year, instead of a heavy skew toward one quarter.

Annual Dividend Growth Trend

Looking back to the early 2010s, Pfizer was paying about $0.22 per share each quarter. From there the board raised the dividend step by step, usually by one or two cents at a time, reaching $0.38 by 2020 and $0.41 by 2022. The move to $0.42 and then $0.43 followed as newer drugs helped replace fading sales from older products.

That pattern shows slow and steady growth instead of big jumps. Long stretches with modest raises often line up with companies that want to keep a payout streak intact, yet still leave room in the budget for research, acquisitions, and debt repayment.

Pfizer Dividend Yield And What It Means

The dividend itself is only half of the story. The other half is the market price of the shares, which turns a fixed dollar payout into a percentage yield. Around late 2025, with the stock trading near the mid twenties and the annual dividend near $1.72, Pfizer’s yield sits in the ballpark of 6.6 to 6.8 percent, near the high end of its range over the past decade.

Independent trackers such as Stock Analysis’s dividend summary for Pfizer show similar figures for yield and annual payout. That kind of third party check can help you confirm that your broker and your own spreadsheet are in the right neighborhood.

How Dividend Yield Is Calculated

The basic formula for yield is straightforward. Take the annual dividend per share and divide it by the current share price. With Pfizer, you divide about $1.72 by a share price around $26 and get a yield close to seven percent. If the share price drops, the yield rises; if the share price rises, the yield falls, as long as the dividend stays the same.

This moving target explains why you will see slightly different yield numbers on different websites on the same day. Some round the inputs, some use trailing twelve month totals, and some use forward estimates, but all of them rely on the same simple idea of dollars received over dollars invested.

How Pfizer Yield Compares To Peers

Within big drug makers, Pfizer’s yield currently stands near the top of the pack. Many peers in the sector pay between two and four percent, while an income rate near seven percent puts Pfizer closer to what investors usually expect from real estate trusts, pipelines, or telecom stocks. That gap reflects a mix of factors, including market concerns over patent cliffs, pricing pressure, and the path back from COVID windfalls.

High yield does not automatically mean a payout is fragile, yet it does signal that the market demands a discount for perceived risk. When you weigh Pfizer against lower yielding rivals, it helps to decide whether that extra income offsets the uncertainties that come with it.

How Much Dividend Pfizer Pays Per Share Over Time

Instead of only asking how much dividend does pfizer pay right now, long term holders focus on the path of the payout through the years. A dividend that grows slowly but steadily can add up to a large cash stream when reinvested, even if the starting yield is modest. In Pfizer’s case, the current yield is high while the growth rate has been in the low single digits.

From 2015 through 2024 the annual dividend per share climbed from just over a dollar to the current $1.72 level. That works out to an average raise of only a few percent a year, yet the company also returned cash through buybacks during parts of that stretch and funded heavy deal activity. The pause in buybacks that followed larger acquisitions tells you that preserving the dividend has stayed near the top of management priorities.

Shares Owned	Annual Dividend Income	Approximate Monthly Cash
25 shares	$43	About $3.60 per month
50 shares	$86	About $7.20 per month
100 shares	$172	About $14.30 per month
250 shares	$430	About $35.80 per month
500 shares	$860	About $71.70 per month
1,000 shares	$1,720	About $143.30 per month
2,000 shares	$3,440	About $286.70 per month

What Can Change Pfizer Dividend Levels

No dividend exists in a vacuum. The board reviews the payout in the context of earnings power, cash on hand, debt obligations, and upcoming investment needs. For Pfizer that means weighing demand for newer drugs, patent exposure on older ones, and the cost of replenishing the pipeline against the desire to keep long time income holders on board.

If profits grow faster than expected and the balance sheet improves, the board has more room to approve raises over time. If profits sag or debt loads stay high, raises may slow, pause, or in a severe case shift into a cut. The company has not cut the dividend in recent decades, yet history never guarantees what comes next.

Earnings And Cash Flow

On recent earnings calls, management has laid out targets that would keep adjusted payout ratios in a range that still leaves headroom for research and business development. Stronger cash generation from drugs outside the fading COVID franchise helps cover the current dividend and creates room for modest raises, even as spending on clinical trials and launches stays heavy.

Income investors often watch free cash flow per share to judge how firm the dividend actually is. When that figure sits well above the annual payout and trends upward over several years, the cash distribution tends to feel sturdier.

Debt, Acquisitions, And Balance Sheet

Pfizer took on debt to fund recent acquisitions, and leadership has said that debt reduction ranks above resuming buybacks. That capital plan matters for the dividend, since interest costs pull from the same pool of cash that could otherwise go to shareholders. As debt rolls down, the board gains more flexibility on raises.

Rating agencies also watch that balance. A steady or improved credit rating usually signals that lenders are comfortable with both the current dividend and the debt load, while a downgrade can hint at pressure to conserve cash.

Board Policy And Track Record

The board has now increased the annual dividend for well over a decade in a row. That track record, backed by hundreds of consecutive quarterly payments, sends a clear message that management wants investors to see Pfizer as a regular income name. Of course, that message only holds weight as long as cash flow and profits stay aligned with the payout.

When you read new dividend declarations or press releases, the main items to watch are the per share amount, the ex-dividend date, and any commentary about capital allocation priorities. Small changes in wording can signal whether the board feels relaxed or cautious about the coming year.

How Pfizer Dividend Might Fit Your Plan

Pfizer sits in a group of large drug companies that throw off meaningful cash and send a large slice of it back to shareholders. For an income focused portfolio, a stock with a yield near seven percent and a long streak of quarterly payments can play a steadying role, especially when paired with holdings that grow faster but pay less today.

At the same time, a high yield never turns a stock into a bond. Earnings can swing, drug trials can miss, regulators can push back on prices, and cash flow can tighten. Before you lean heavily on Pfizer or any single name for income, stress test your plan under slower growth or a dividend freeze, and speak with a licensed adviser who understands your full financial situation.

So, how much dividend does pfizer pay? Right now the headline number sits near $0.43 per share each quarter, or about $1.72 a year, which works out to a yield in the mid single digits based on recent prices. The long payout streak and steady raise history give that stream some appeal, yet the market clearly bakes in risk through the discounted share price. Your task is to weigh that trade off in the context of your goals, time horizon, and tolerance for bumps along the way.